TY - JOUR AU - Vlachostergios, Panagiotis J. AU - Jakubowski, Christopher AU - Tagawa, Scott T. PY - 2017 TI - Trimodality therapy in variant urothelial carcinoma: choose wisely JF - Translational Andrology and Urology; Vol 6, No 2 (April 29, 2017): Translational Andrology and Urology (Global Urology) Y2 - 2017 KW - N2 - Trimodality bladder-sparing therapy with maximal transurethral resection (TUR) followed by combined chemoradiation is an alternative to neoadjuvant chemotherapy followed by radical cystectomy (RC) in optimally selected patients treated in expert multidisciplinary centers. Little has been studied regarding the impact of variant urothelial histology when utilizing a trimodality therapy (TMT) approach. Investigators from Boston, Massachusetts retrospectively reviewed their long-term experience with this approach. UR - https://tau.amegroups.org/article/view/14481